All Providers

To book an appontment with Dr Shiers visit his organisation profile on HealthPad.

Harry Shiers qualified from University College London in 1987. His philosophy is to be trained in the latest techniques and technologies of dentistry in order to achieve the best of one’s abilities and truly understand the subject

He is a member of the Royal College of Surgeons, of the british academy of Cosmetic dentistry and a Master of Science in Implant Dentistry.

Sebastian Lucas made his name in the early 90s with his pioneering work on AIDS.

Having performed autopsies on more than 1000 people who died of AIDS in Africa and England, Lucas knows as much as anyone about the multiple manifestations of the disease in different environments, and his findings have had a critical influence on the management and treatment of people with HIV. "

Alan Gelb is a senior fellow at the Center for Global Development. His recent research includes aid and development outcomes, the transition from planned to market economies, the development applications of biometric ID technology, and the special development challenges of resource-rich countries. He was previously director of development policy at the World Bank and chief economist for the bank’s Africa region and staff director for the 1996 World Development Report “From Plan to Market.

Mike Farrar is an independent management consultant and former Chief Executive of the NHS Confederation. He joined the organisation in May 2011.

Mike was chief executive of the North West England SHA from May 2006 to April 2011. He was previously chief executive of West Yorkshire and South Yorkshire Strategic Health Authorities, chief executive of Tees Valley Health Authority and head of primary care at the Department of Health.

Mike was also a board member of Sport England, and in August 2009 was appointed as National Tsar for Sport and Health. Mike was also awarded the CBE in 2005 for services to the NHS and is an honorary fellow of the University of Central Lancashire.

Dr. Nazir Rampersaud is a research fellow at the UCL School of Pharmacy specializing in the development and testing of novel compounds for the treatment of Parkinson's disease. More specifically, Dr. Rampersaud's current research entails examining Exendin-4, a glucagon-like peptide 1 receptor agonist, in the treatment of both motor and nonmotor symptoms of Parkinson pathology. His research has been funded by Parkinson's UK, the Cure Parkinson's Trust, and the Michael J. Fox foundation.

Sir Michael Marmot is Professor of Epidemiology and Public Health at University College, London and Director of the Institute of Health Equity (UCL Department of Epidemiology & Public Health).

Professor Marmot has been awarded honorary doctorates from 14 universities and has led research groups on health inequalities for 40 years. He was Chair of the Commission on Social Determinants of Health (CSDH), which was set up by the World Health Organization in 2005, and produced the report entitled: ‘Closing the Gap in a Generation’ in August 2008.

At the request of the British Government, he conducted the Strategic Review of Health Inequalities in England, which published its report 'Fair Society, Healthy Lives' (aka The Marmot Review) in February 2010. This was followed by the European Review of Social Determinants of Health and the Health Divide, for WHO Europe in 2014. He chaired the Breast Screening Review for the NHS National Cancer Action Team and from 2011-2004 was a member of The Lancet-University of Oslo Commission on Global Governance for Health. He is currently Chair of the PAHO Commission on Equity and Health Inequalities in the Region of the Americas.

He set up the Whitehall II Studies of British Civil Servants, investigating explanations for the striking inverse social gradient in morbidity and mortality. He leads the English Longitudinal Study of Ageing (ELSA) and is engaged in several international research efforts on the social determinants of health. He served as President of the British Medical Association (BMA) in 2010-2011, and President of the World Medical Association (2015-16) and he is President of the British Lung Foundation. He is an Honorary Fellow of the American College of Epidemiology, a Fellow of the Academy of Medical Sciences, an Honorary Fellow of the British Academy, and an Honorary Fellow of the Faculty of Public Health of the Royal College of Physicians. He was a member of the Royal Commission on Environmental Pollution for six years and in 2000 he was knighted by Her Majesty The Queen, for services to epidemiology and the understanding of health inequalities.

Internationally acclaimed, Professor Marmot is a Foreign Associate Member of the Institute of Medicine (IOM), and a former Vice President of the Academia Europaea. He won the Balzan Prize for Epidemiology in 2004, gave the Harveian Oration in 2006, and won the William B. Graham Prize for Health Services Research in 2008.

Pat O’Brien has been a Consultant & Honorary Senior Lecturer in Obstetrics and Gynaecology at University College London Hospitals since 1999. He is currently the Divisional Clinical Director for Women's Health. He specialises in Maternal Medicine and high-risk obstetrics, and at UCLH jointly runs a multi-disciplinary antenatal clinic involving consultants in Fetal Medicine, Cardiology, Haematology, Diabetes, Anaesthesia, and an Obstetric Physician. He has a particular interest in medical complications of pregnancy. He lectures widely in the UK and abroad, and runs courses on fetal monitoring, medical problems on the delivery suite, psychiatric problems and cardiac disorders in pregnancy.

He is the Chair of the International Division of the Institute for Women’s Health in London and a media spokesperson for the Royal College of Obstetricians & Gynaecologists. He is a reviewer for the Cochrane Collaboration and several medical journals. He sits on the Editorial Boards of the Journal of Obstetrics & Gynaecology and the BJM. He examines for the DRCOG examination. He has been a member of the obstetric guideline development group of the National Institute for Clinical Excellence in the UK. He also works regularly with BBC Television (British Broadcasting Corporation) as an obstetric advisor.

Dr Nilesh Pareek in an interventional cardiologist at King’s College Hospital NHS Foundation Trust, London.

He held a previous position as a specialist Registrar in Cardiology at the Royal Sussex County Hospital and was a Fellow in Interventional Cardiology within the London Deanery.

I studied basic neuroscience at Leeds and UCL before undertaking a PhD at Imperial College.

During my doctoral studies, I developed an interest in studying the central regulation of energy and glucose homeostasis using in vivo imaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET).

I subsequently held brief post-doctoral positions at the University of Oxford and MRC London Institute of Science before a lengthier stay at the BMBF- and DFG-funded obesity research centres in Leipzig University, Germany.

I am currently Lead Scientist at the Department of Experimental Surgery situated at the University of Wuerzburg where I am working on the mechanisms of weight loss after gastric bypass surgery using animal models. 

Professor Sikora is a British physician specialising in oncology. He is medical director of Rutherford Health, and Director of Medical Oncology at the Bahamas Cancer Centre. He is also Professor of Medicine at the University of Buckingham, and a partner in and dean of Buckingham's medical school.

Professor Sikora studied medical science and biochemistry at Cambridge, where he obtained a double first.

After clinical training he became a house physician at The Middlesex Hospital and registrar in oncology at St Bartholomew’s Hospital. He later became a research student at the MRC Laboratory for Molecular Biology in Cambridge working with Nobel Prize winner, Dr Sydney Brenner.

He obtained his PhD and became a clinical fellow at Stanford University, California before returning to direct the Ludwig Institute in Cambridge.

He has been Clinical Director for Cancer Services at Hammersmith for 12 years and established a major cancer research laboratory there funded by the Imperial Cancer Research Fund. He chaired Help Hammer Cancer, an appeal that raised £8m towards the construction of the new Cancer Centre at Hammersmith. He became Deputy Director (Clinical Research) of the ICRF.From 1997 to 1999 he was Chief of the WHO Cancer Program and from 1999 to 2002 and Vice President, Global Clinical Research (Oncology) at Pharmacia Corporation.

He has published over 300 papers and written or edited 20 books and is on the editorial board of several journals and is the founding editor of Gene Therapy and Cancer Strategy.

He was a member of the UK Health Department’s Expert Advisory Group on Cancer (the Calman-Hine Committee), the Committee on Safety of Medicines and remains an adviser to the WHO. He currently directs a cancer drug donation programme in Africa.